Ansell Healthcare announces its newest innovation to reduce skin irritation and improve skin condition; the Derma Prene® IsoTouch® HydraSoft® synthetic polyisoprene, powder-free surgical glove is designed as a moisturizing glove that is designed to prevent Type I latex allergic reactions and restores and improves hands.
Â
This glove combines proprietary skin-moisturizing technology with the most advanced latex-free synthetic material to restore hand condition without risk of Type I allergic reactions. It is ideal for delicate procedures in ophthalmic, micro, and cardiovascular surgery without the risks associated with natural rubber latex sensitization. The Derma Prene® IsoTouch® HydraSoft® can also serve as an underglove, as its micro-thickness allows for comfortable double-gloving. It offers exceptional dexterity, tactile sensitivity and at the same time, outstanding strength and barrier protection.
For more information, visit www.ansellhealthcare.com
The Guardians of Animal Health: Who Are Veterinary Infection Preventionists?
March 21st 2025Veterinary infection control experts Leslie Kollmann, BS, AAS, CVT, CIC, Denise Waiting, LVT, and Leslie Landis, LVT, BS, discuss challenges, zoonotic disease risks, and the importance of education, collaboration, and resource development in animal care facilities.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.